Gore Mutual Insurance Company selects Coreio Inc. to provide full suite of IT asset lifecycle and end user managed services

[ad_1]

Coreio Inc. and Gore Mutual Insurance Company (Gore Mutual) announced today that they have entered into a contract for Coreio to provide IT Asset Lifecycle and End User Managed Services, including IT Service Management (ITSM), across their Canadian operations. In a move that is expected to accelerate Gore Mutual’s digital transformation goals, Coreio is to begin providing a comprehensive suite of back-office support services utilizing a Device-as-a-Service (DaaS) model that includes all warehousing, procurement, configuration, imaging, fulfillment, and ongoing support of their IT devices.

As part of the agreement, Coreio will provide Gore Mutual with a Service Desk, based onshore, to support its End User community consisting of a remote and distributed workforce across Canada. As an Elite ServiceNow® partner, Coreio will deliver services to enhance the current operations while simultaneously building out and expanding capabilities, in line with Gore Mutual’s Next Horizon initiatives to modernize and digitize its workplace. ServiceNow® provides key tooling, automation, process, reporting and capabilities which will assist Coreio in the delivery of services to achieve Gore Mutual’s overall objectives to reposition the company as a purpose driven, digitally-led national insurer.

Coreio was chosen as Gore Mutual’s trusted advisor, marking a partnership between two leading Canadian organizations, because of a mutually shared vision for the modern workplace and to deliver world-class support to remote and distributed workforces in response to fast-changing customer expectations. “Coreio is excited to be working with Gore Mutual to modernize their IT assets and support processes while reducing year-over-year operating costs, as well as optimizing and improving the overall experience for their End User community across Canada,” said Rob Muroff, Co-Owner and Chief Executive Officer at Coreio.

“The agreement with Coreio allows us to bring additional capabilities to make insightful data-driven decisions, enhance system workflows and simplify business processes,” says Raj Utraja, Interim Chief Technology Officer. “For the past two years, we’ve been very agile to ensure all staff could work remotely enabled by best and secure technology solutions.”

Coreio is a 100% Canadian owned and operated IT Services Company, and an Elite ServiceNow® Partner, doing business throughout Canada and the US since 1981, focused on IT Infrastructure and Operations. Coreio provides a variety of managed IT services that covers onsite IT support, data centre and networking, asset lifecycle management, request/incident management as well as strategic advisory services to enterprise clients regarding Infrastructure and Operations, and technology solutions for ServiceNow® including an MSP offering.

More information is available on Coreio’s website at http://www.coreio.com and on Twitter and LinkedIn.

About Gore Mutual

Built on a foundation of financial strength for more than 180 years, Gore Mutual Insurance Company is one of Canada’s first property and casualty insurance companies. Based in Cambridge, Ontario, we are a Canadian mutual company, with more than 500 employees focused on delivering outstanding insurance products and services to customers. In 2019, we launched our Next Horizon strategy—a 10-year plan—to transform Gore Mutual from a mid-size regional carrier to a national-scale insurer with an investment of $50 million over three years invested in talent and technology.

We continue to strengthen Canadian communities through the Gore Mutual Foundation. Over the past 22 years, we have donated more than $10 million to over 790 charities.

For more information, visit goremutual.ca or Gore Mutual’s Twitter, Facebook, Instagram and LinkedIn pages.

Media contacts:

Nick Varone

Vice President of Sales and Marketing

Coreio Inc.

nick.varone@coreio.com

(905) 850-2987

Ryan Strang

Corporate Communications Manager

Gore Mutual Insurance Company

rstrang@goremutual.ca

(226) 220-2699

Share article on social media or email:



[ad_2]

Dr. Jacqueline Lappin wins gender discrimination case against Baylor Scott & White

[ad_1]

Jacqueline Lappin, MD

Dr. Jacqueline Lappin was awarded more than $300,000.

Most women don’t have the means to fight back. But if you do – step up. Change must come.

Dr. Jacqueline Lappin, a renowned transplant surgeon with over three decades of experience, has won a gender discrimination lawsuit against Baylor Scott & White Medical Center in Temple after being abruptly terminated.

In an arbitration proceeding, the Hon. Catherine M. Stone determined that Scott & White’s allegations that Dr. Lappin, the hospital’s former division director of abdominal transplant surgery, had engaged in “conduct unbecoming a leader” and “abusive behavior” were untrue. Instead, Judge Stone found that Dr. Lappin was a victim of gender discrimination and unfair treatment by Scott & White.

“Based on my review of the record and giving due regard to the credible evidence… Dr. Lappin has established her claim for wrongful termination based on gender/sex discrimination,” Judge Stone wrote, awarding Dr. Lappin more than $300,000 .

Under American Arbitration Association rules, the award is not confidential and may be filed in any court of competent jurisdiction. Dr. Lappin has filed the award (case number AAA NO. 01-18-0002-1978) in U.S. federal court in Waco.

The outcome of the case raises larger questions about the culture at the hospital and unequal treatment at the medical center.

“It is uncontroverted that all other division directors are male and that none was terminated for conduct unbecoming a leader, even though several of those division directors were specifically counseled about their anger issues or ‘mistreatment’ of others,” wrote Judge Stone. Dr. Lappin said she hopes her story inspires others in her situation to come forward, but acknowledges “this was a painful, costly and brutal fight.”

“Most women don’t have the means to fight back. But if you do – step up. Change must come,” she said.

Dr. Lappin joined Scott & White in 2013 as the division director of abdominal transplant surgery. At that time, the medical center was performing 20-30 kidney transplants and 1-2 pancreas transplants a year.

Under her leadership, by 2017 that number rose to 128 kidney and 10-15 pancreas transplants per year, putting Scott & White among the top three pancreas programs in Texas and earning the transplant program a “Center of Excellence” certification from Blue Cross Blue Shield and Aetna. These were just some of her accomplishments in her 4.5-year tenure.

But beginning in late 2017, Dr. Lappin found herself marginalized and accused of “disruptive” and “inappropriate” behavior. The hospital terminated her without warning in March 2018.

“I was completely gutted,” Dr. Lappin said about her termination. “I wasn’t even allowed to pack up my office. I had patients who were fresh transplants. But I was no longer allowed to treat them.”

Colleagues described Dr. Lappin as “gracious,” “professional” and “inspiring.” One called her termination “a huge loss for our community.”

Dr. Lappin said she feels vindicated by the decision, but remains troubled by her experience. She said that patient care suffers in any medical setting that has an “old boys’ club” culture – where male doctors are the power brokers, and others walk on eggshells around them.

Share article on social media or email:

[ad_2]

Akamas joins Dynatrace’s New DevSecOps Automation Alliance Partner Program

[ad_1]

News Image

Akamas AI-powered optimization

We are excited to provide our customers with easy access to integrations with best-in-class solutions like Akamas.

Akamas, a leader in autonomous performance optimization solutions powered by AI, today announced it has joined Dynatrace’s new DevSecOps Automation Alliance Partner Program.

Software intelligence company Dynatrace has selected an elite set of industry-leading DevSecOps solutions to participate in its new partner program, which allows customers to easily integrate these solutions with Dynatrace®. With just a few clicks, teams can combine the power of Akamas with the Dynatrace platform’s broad observability, run-time application security, and advanced AIOps capabilities, enabling them to reduce routine manual effort associated with managing complex toolchains, and deliver better quality releases faster, and more securely.

“We are honored and excited to be a launch partner in Dynatrace’s new DevSecOps Automation Alliance Partner Program, which will allow us to extend the full power of our integrated solutions to our joint customers,” said Stefano Doni, Chief Technology Officer, Akamas. “By integrating Akamas’ AI-powered optimization with Dynatrace, DevSecOps and SRE teams can now implement a continuous optimization process that automatically maximizes service performance, resilience, and cost efficiency.”

“We are excited to provide our customers with easy access to integrations with best-in-class solutions like Akamas,” said Mike Maciag, Chief Marketing Officer, Dynatrace. “By enabling DevSecOps and SRE teams to easily combine Dynatrace’s industry-leading observability, application security, and AIOps with Akamas’ AI-powered optimization, we are empowering teams to stop wasting time on routine manual tasks and instead focus on delivering better quality software faster, more securely.”

In addition to an Akamas integration to be launched on the Dynatrace Hub, Akamas and Dynatrace will also be collaborating on a number of go-to-market activities and engagements for prospects, customers, and shared channel partners to ensure successful enablement and best practices for this new solution at enterprise scale.

About Dynatrace

Dynatrace provides software intelligence to simplify cloud complexity and accelerate digital transformation. With automatic and intelligent observability at scale, our all-in-one platform delivers precise answers about the performance and security of applications, the underlying infrastructure, and the experience of all users to enable organizations to innovate faster, collaborate more efficiently, and deliver more value with dramatically less effort. That’s why many of the world’s largest enterprises trust Dynatrace® to modernize and automate cloud operations, release better software faster, and deliver unrivaled digital experiences.

To learn more about how Dynatrace can help your business, visit https://www.dynatrace.com, visit our blog, and follow us on Twitter @dynatrace.

About Akamas

Akamas is the AI-powered autonomous optimization solution that enables enterprises and online businesses to deliver unprecedented levels of service performance and resilience at minimum cost. Built by veterans in performance engineering and data science, Akamas exploits advanced machine learning techniques to optimize hundreds of interdependent service configuration parameters while matching both technical and business goals. Akamas customers include leading enterprise organizations in financial and online services. Akamas is a company of Moviri and counts Dynatrace, Tricentis, Micro Focus, and Splunk among its partners. Headquartered in Milan, Akamas has offices in Boston, Los Angeles, and Singapore.

To learn more about Akamas, visit https://www.akamas.io

Share article on social media or email:

[ad_2]

Try These Healthy Valentine’s Day Ideas and Self Care Tips from GOLO

[ad_1]

Try these Valentine’s Day ideas

Healthy Valentine’s Day Ideas and Self Care Tips from GOLO

“With so many tempting and tasty Valentine’s Day treats surrounding us, one of the biggest challenges is finding a way to celebrate the holiday while also staying on track with personal wellness goals,” says Jennifer Brooks, President, GOLO LLC.

While Valentine’s Day is the perfect time of year to celebrate love and affection for others, it is also an opportunity to check in on your own personal wellness. Just in time for the big day, GOLO, the pioneering wellness solutions company, has some healthy Valentine’s Day ideas that can help keep the body moving and the mind focused – whether prepping for a day of quiet personal introspection or enjoying date night with a significant other.

“With so many tempting and tasty Valentine’s Day treats surrounding us, one of the biggest challenges is finding a way to celebrate the holiday while also staying on track with personal wellness goals,” says Jennifer Brooks, President, GOLO LLC. “That’s why we developed a list of healthy Valentine’s Day ideas to help get the most out of the day and every day.”

Try these healthy Valentine’s Day ideas from GOLO:


  • Understand your own needs and make them a priority: When it comes to personal health and wellness, there is no “one-size-fits-all” solution that works the same for everyone. It’s important to create a plan and set goals specific to your own unique needs.
  • Move your body: Before, during, and after Valentine’s Day, make time to get up and active. Even a little bit of exercise can help improve your physical health while also stimulating you mentally.
  • Get Organized: It’s Valentine’s Day, so let’s start in the kitchen. Whether it’s a romantic dinner or a quick snack before you head out the door, the more organized your kitchen is, the easier it will be to make better eating choices. Keeping your surroundings organized can also help minimize stress.
  • Consider an accountability partner: Holding yourself accountable to a specific health goal can be difficult. You may not always feel up to the challenge of eating the best foods or exercising, particularly on Valentine’s Day. But when you commit to a wellness goal with a friend or loved one, especially if they have similar aspirations, you increase your chances of success.
  • Quiet time: Take 10-15 minutes to incorporate a little healthy “you time” into your day. As the saying goes—you can only love someone as much as you love yourself.

Wherever you are on your health and wellness journey, GOLO offers a range of innovative products designed to help, including the GOLO for Life Plan®, a game-changing nutritional approach to losing weight, and a healthy alternative to conventional dieting. The program includes GOLO Release® (an all-natural dietary supplement), the GOLO Metabolic Plan® (a healthy balanced meal plan), access to personal coaches, and online tools.

ABOUT GOLO® Products:

GOLO® products provide safe solutions to weight loss and wellness while helping individuals transition to a healthier and sustainable lifestyle. GOLO has reached over two million people worldwide who now have a chance at healthy, sustainable, and affordable weight loss. For more information about the GOLO for Life® plan, visit golo.com or call 800-730-4656.

Share article on social media or email:

[ad_2]

New Testing of Intimate Care Products Sparks Concern Over Links to Adverse Impacts on Vaginal Microbiome Health

[ad_1]

“There is a strong need for safety standards to ensure that vaginally applied products are safe and healthy for sensitive vaginal tissue and that they do not adversely affect the vaginal microbiome,” said Dr. Williams of Black Women for Wellness. “Companies must and can do better.”

Today, national health nonprofits, Women’s Voices for the Earth (WVE) and Black Women for Wellness, advocacy research organization, Apothercare, and testing facility, CLIP Labs, released independent product-testing results that reveal potential harm to vaginal health from intimate care products. Specifically, products were found to effectively inhibit the growth of the “good” bacteria, lactobacilli — lactobacilli are necessary for a healthy vaginal microbiome. An upset or imbalance of lactobacilli are linked to increased risks of bacterial vaginosis (or BV). Of particular concern is how these products are disproportionately impacting the vaginal microbiome of Black women, who report more frequent use of intimate care products.

Bacterial vaginosis (a type of vaginitis) is an inflammation of the vulva or vagina. Acute symptoms often include itching, burning, unusual discharge, or irritation.

“So many vaginal products are marketed to us as beneficial to our health – but there is no standard testing required to ensure these products don’t have adverse effects,” said Pam Miles, Founder of Apothercare who led the product-testing. “At a minimum, manufacturers should ensure that vaginal products do not adversely affect lactobacilli, which are vital to a healthy vagina. It was surprising to see that product manufacturers had not even taken this simple step, especially with potentially significant health impacts on the very part of the body these products are designed for.”

The study looked at eleven products marketed for intimate use, including lubricants, vaginal moisturizers, washes, deodorants, and vaginal suppositories. Not all the tested products inhibited lactobacilli. Three products specifically inhibited growth of all four types of lactobacilli tested. One product particularly, had a greater impact on inhibiting Lactobacillus iners, compared to the other three types of lactobacilli. Lactobacillus iners is a type of lactobacillus more common to be dominant in Black women. This raises considerable concern for Black women as studies show that Black women more frequently report using douche and other intimate care products than white women, putting them at increased risk of exposure

“People of color are bearing the brunt of this toxic exposure and it is especially egregious that these products, marketed and sold under the guise of vaginal and sexual health, are in fact exposing people to chemicals that can negatively impact their reproductive well-being, and cause undue harm,” said Dr. Astrid Williams, Environmental Justice Manager at Black Women for Wellness. “It is unacceptable that in the absence of regulation protections and basic safety-standards, products linked to these health concerns are ending up on our shelves in the first place.”

It is estimated that at least 75% of women in the U.S. will experience episodes of vaginitis at some point during their life.[1] A 2019 snapshot survey of over 1,500 women in Boston found that more than a third reported they were currently experiencing one or more moderate to severe symptoms such as vulvar or vaginal itching, burning, discharge, dryness and/or pain.[2]

“Vaginal burning, itching and irritation are so common we have simply come to accept it, or worse blame ourselves for the problem,” said Alexandra Scranton, WVE’s Director of Science and Research. “WVE has long been alarmed about the ingredients found in intimate care products, how they impact sensitive vulvar and vaginal issues, and if the very creams, washes and wipes people are encouraged to use in hopes of lessening their symptoms might actually be worsening the problem. It’s a vicious cycle. These new testing results reaffirm our concerns and the need for stronger regulations and more research into these products.”

Health concerns about vaginosis aren’t simply limited to discomfort. The potential impacts of disruption to vaginal microbiota are profound. Studies have shown that vaginitis and abnormal vaginal bacteria are associated with a significantly higher risk of pre-term birth and miscarriage [3] and increase risks of contracting sexually-transmitted diseases such as HIV,[4] chlamydia and Gonorrhea.[5] Preliminary research also indicates that disrupted vaginal bacteria may significantly increase the risk of cervical cancer.[6]

This new testing joins the growing evidence linking the use of intimate care products to vaginal infections. For example, a 2013 study tested a store-bought “feminine” moisturizer, lubricant and spermicide and found that all three products effectively killed lactobacilli [7]— while numerous studies have found higher rates of abnormal vaginal bacteria and higher rates of bacterial vaginosis in people who douche regularly.[8][9][10][11]

Intimate care products are regulated as cosmetics in the United States. Companies can use virtually any raw material in a finished product without FDA pre-market safety testing or review. Companies are also not required to test the impact of an intimate care product on the vaginal microbiome. In addition to bacterial vaginosis, ingredients found in intimate care products have also been linked to cancer, reproductive harm, allergies, hormone disruption and more.

NEW PRODUCT TRENDS, MORE EXPOSURES

Testing also included newer trends in the market, including CBD & THC infused vaginal suppositories and a topical serum marketed to women for increased libido. The topical serum performed particularly poorly, completely inhibiting growth of all four types of lactobacilli. The other cannabis infused products (vaginal suppositories) including those with THC did not have any adverse effects on lactobacilli.

“With states legalizing cannabis and hemp derived CBD, there has been an explosion of new and unregulated intimate care products. Cannabis based intimate care products are marketed for sleep, libido, menstrual cramp relief. Simply, we wanted to try some of the products, but couldn’t find any information about safety and efficacy,” said Miles of Apothercare. “The marketing has preceded the science. We knew we needed to test.”

“We are overwhelmed with products designed for our vaginas and vulvas. There are sprays, douches, washes, wipes, powders, creams, lubes, moisturizers, gels, dry shampoos and more. There are products specific for teens, for tweens, for moms, for menstruators, for pre-sex, post-sex, post-workout, for wellness, and self-care,” said Amber Garcia, WVE’s Executive Director. “It’s exhausting, unnecessary and potentially dangerous. The message that’s being perpetuated is that our bodies are dirty and unclean, and the lack of safety standards for these products means we can be exposed to ingredients that can harm our health.”

“With endless, unregulated products pushed on us, it’s no wonder vaginitis is so common and widespread,” said Garcia. “And instead of addressing the underlying problem, we’re introduced with a new way to wash it away, which may be causing even more harm.”

“There is a strong need for safety standards to ensure that vaginally applied products are safe and healthy for sensitive vaginal tissue and that they do not adversely affect the vaginal microbiome,” said Dr. Williams. “Companies must and can do better.”

View full testing results and product information.

###

ABOUT Women’s Voices for the Earth (WVE)

Founded in 1995, Women’s Voices for the Earth is a national environmental health organization that works to amplify women’s voices to eliminate toxic chemicals that harm our health and communities. http://www.womensvoices.org

ABOUT Black Women for Wellness

Black Women for Wellness is committed to the health and well-being of Black women and girls through health education, empowerment and advocacy. https://www.bwwla.org

ABOUT Apothercare

Apothercare partners with scientists on the cutting edge of women’s health research. Our aim is to promote advances in women’s health products and pharmaceuticals. We cut through the hype and bring the science to the consumer. https://apothercare.com

ABOUT CLIP Labs

CLIP Labs is an independent, third-party analytical cannabis and hemp testing lab which focuses on providing accurate and reliable solutions for our clients. Whether our clients are conducting research and development or compliance testing of cannabis and hemp products, our ISO-17025 accredited lab is staffed with highly experienced scientists focused on safety and quality. CLIP Labs is headquartered in San Diego, California. For more information, visit http://www.cliplabs.net.

———————————-

[1] Watson LJ, James KE, Hatoum Moeller IJ, Mitchell CM. Vulvovaginal Discomfort Is Common in Both Premenopausal and Postmenopausal Women. J Low Genit Tract Dis. 2019;23(2):164-169. doi:10.1097/LGT.0000000000000460

[2] Lanis A, Talib HJ, Dodson N. Prepubertal and Adolescent Vulvovaginitis: What to Do When a Girl Reports Vaginal Discharge. Pediatr Ann. 2020;49(4):e170-e175. doi:10.3928/19382359-20200317-01

[3] Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG. 2009;116(10):1315-1324. doi:10.1111/j.1471-0528.2009.02237.x

[4] Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008;22(12):1493-1501. doi:10.1097/QAD.0b013e3283021a37

[5] Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003;36(5):663-668. doi:10.1086/367658

[6] Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?. Microbiome. 2016;4(1):58. Published 2016 Nov 1. doi:10.1186/s40168-016-0203-0

[7] Fashemi B, Delaney ML, Onderdonk AB, and Fichorova RN. (2013) Effects of feminine hygiene products on the vaginal mucosal biome. Microbial Ecology in Health and Disease. Vol. 24. 19703. 2013.

[8] Crann SE, Cunningham S, Albert A, Money DM, O’Doherty KC. Vaginal health and hygiene practices and product use in Canada: a national cross-sectional survey. BMC Womens Health. 2018;18(1):52. Published 2018 Mar 23. doi:10.1186/s12905-018-0543-y

[9] Coudray MS, Sheehan DM, Li T, Cook RL, Schwebke J, Madhivanan P. Factors Associated With the Recurrence, Persistence, and Clearance of Asymptomatic Bacterial Vaginosis Among Young African American Women: A Repeated-Measures Latent Class Analysis. Sex Transm Dis. 2020 Dec;47(12):832-839

[10] Kim KM, Choi JS. Female university students’ menstrual-hygiene management and factors associated with genitourinary-tract infections in Korea. Women Health. 2020 May-Jun;60(5):559-569

[11] Marconi C, El-Zein M, Ravel J, Ma B, Lima MD, Carvalho NS, Alves RRF, Parada CMGL, Leite SHM, Giraldo PC, Gonçalves AK, Franco EL, Silva MG. Characterization of the Vaginal Microbiome in Women of Reproductive Age From 5 Regions in Brazil. Sex Transm Dis. 2020 Aug;47(8):562-569

[ad_2]

Eduardo M. Sotomayor, MD, Appointed Chair of Lymphoma Research Foundation Mantle Cell Lymphoma Consortium

[ad_1]

Eduardo M. Sotomayor

“I’m honored to lead this vital consortium dedicated to improving clinical outcomes for all those impacted by mantle cell lymphoma, a disease that has been my passion to study for the past two decades,” said Dr. Sotomayor.

The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services. LRF has appointed Eduardo M. Sotomayor, MD, director of Tampa General Hospital’s Cancer Institute, as chair of its Mantle Cell Lymphoma Consortium (MCLC) Executive Committee.

The Mantle Cell Lymphoma Consortium Executive Committee helps to guide the MCLC by identifying gaps in research and patient care for this historically understudied patient population. Since its inception in 2003, the Mantle Cell Lymphoma Workshop brings together leading international experts to discuss the latest research findings, foster collaboration within the mantle cell lymphoma (MCL) research community, create new directions for research, and ultimately improve diagnosis and treatment for this disease. The annual proceedings paper highlighting key themes and discussions from the MCL Workshop is considered a blueprint for future MCL research and sought out by researchers and clinicians worldwide. The MCLC is composed of almost 150 international laboratory and clinical scientists whose research is focused on MCL.

“Dr. Sotomayor is a world-renowned expert in mantle cell lymphoma and dedicated member of our prestigious Scientific Advisory Board,” said Meghan Gutierrez, Chief Executive Officer at the Lymphoma Research Foundation. “His contributions to the field of mantle cell lymphoma research have been critical to our understanding of this disease and we look forward to witnessing the impact the MCLC will have under his leadership.”

Dr. Eduardo Sotomayor received his medical degree from the Federico Villarreal National University School of Medicine, Lima, Peru. He completed his internal medicine residency at Jackson Memorial Medical Center, University of Miami School of Medicine, and fellowship in medical oncology at Johns Hopkins University School of Medicine, Baltimore.

Dr. Sotomayor is currently the director of the newly established Tampa General Hospital Cancer Institute. His research interests are in the area of immunobiology and immunotherapy of non-Hodgkin lymphomas (NHL) with special emphasis in MCL. He serves on the LRF Scientific Advisory Board (SAB) and is also a member of several committees in the American Association for Cancer Research (AACR).

“I’m honored to lead this vital consortium dedicated to improving clinical outcomes for all those impacted by mantle cell lymphoma, a disease that has been my passion to study for the past two decades,” said Dr. Sotomayor. “I am excited to see what my colleagues and I will be accomplishing during my tenure, as we advance future breakthroughs in targeted therapy and immunotherapies for MCL patients.”

Dr. Sotomayor joined Tampa General Hospital from the George Washington University Cancer Center in Washington, D.C., where he directed all cancer care and research activities during the past five years. He is an internationally renowned expert in mantle cell lymphoma (MCL), who has held leadership roles in nationally ranked cancer programs as well as in major national cancer organizations such as the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO), American Association of Cancer Institutes (AACI) and American Association of Cancer Research (AACR).

Mantle Cell lymphoma is typically an aggressive, rare, form of non-Hodgkin lymphoma (NHL) that arises from cells originating in the “mantle zone.” MCL accounts for roughly 6 percent of all NHL cases in the United States.

For more information about the LRF Mantle Cell Lymphoma Consortium, Initiative and Workshop, visit lymphoma.org/mclscientificimeetings.

Share article on social media or email:

[ad_2]

Impact Advisors Hires Sandeep Sabharwal

[ad_1]

Sandeep’s experience and track record will help us continue to build out and grow Impact Advisors into an industry-leading healthcare consulting firm.

Impact Advisors, a leading healthcare consultancy providing strategy, operations, revenue cycle and technology services, announced that Sandeep Sabharwal has joined its senior leadership team as a managing partner and member of the Board. He will be leading the firm’s efforts to accelerate growth and enhance it’s position as a leader in the market.

“We are excited to have Sandeep join our senior leadership team and board,” said John Klare, Managing Partner of Impact Advisors. “Sandeep’s experience and track record will help us continue to build out and grow Impact Advisors into an industry-leading healthcare consulting firm. In addition, his commitment to culture and passion for developing high performance teams is an excellent match for our firm and our values.”

Sandeep has served in numerous leadership roles during his more than 25-year career, mostly in healthcare, and joins Impact Advisors from Accenture. Sandeep was managing director and part of Accenture’s Health & Public Service US Northeast leadership team. In his last role, he led growth for all Health & Public Service business across the US Northeast. In the last two years, he doubled the sales. Prior to Accenture, Sandeep worked at Cognizant where he was global client partner for a Fortune 10 multinational healthcare company and led a 2000+ person global team. Prior to Cognizant, Sandeep worked at Mindtree in a variety of leadership roles, including Country Head for Australia and New Zealand, which he started from scratch.

“I am honored to join Impact Advisors and look forward to working closely with our talented associates as we continue to grow Impact Advisors into one of the leading healthcare consulting firms. I look forward to expanding opportunities for the firm’s clients and associates while affecting real change in healthcare and enhancing value for our shareholders,” Sandeep said.

About Impact Advisors

Impact Advisors is a nationally recognized healthcare management consulting and technology services firm that is solving some of the toughest challenges in the industry by delivering strategic advisory, technology implementation and operational improvement services. The comprehensive suite of strategic planning, digital health, clinical optimization and revenue cycle services spans the lifecycle of clients’ needs. The experienced team has a powerful combination of clinical, revenue, operations, consulting and information technology experience. The firm has earned several prestigious industry and workplace awards including Best in KLAS® for 15 consecutive years, Healthcare Informatics HCI 100, Crain’s Chicago Business Fast Fifty, as well as “best place to work” awards from: Modern Healthcare, Consulting Magazine, Becker’s Hospital Review and Achievers. For more information about Impact Advisors, visit http://www.impact-advisors.com.

Share article on social media or email:

[ad_2]

Announcing Fyncr, the First All-in-One Credit Card Bill Payments Mobile App

[ad_1]

News Image

At Fyncr, we aim to revolutionize the bill payment experience and transform it into a rewarding one, giving the customers the financial freedom to do the things that they care about,” said Sahil Kumar, CEO, and founder of Fyncr.

Remove the pressure of paying multiple credit card bills on different banking platforms with Fyncr, the first all-in-one-card bill payment mobile application in the United States that aims to help people better manage their credit cards, save more and spend intelligently. Fyncr is the only platform that allows every credit card owner to securely store, view, and pay all their credit cards from any bank account and earn reward points called FYX to enjoy unbeatable deals, discounts, and freebies within the app from over 500 brands in the country.

Most Americans have two financial things in common: they use more than one credit card and value financial stability. While credit cards enable freedom, flexibility and financial autonomy, people often get lost in the tangle of managing multiple credit cards or paying the bills on time.

Through Fyncr’s secure, automated payment system, customers don’t need to use different banking apps to pay their credit card bills on time, boosting their creditworthiness and easing the financial burden of millions of Americans.

“At Fyncr, we aim to revolutionize the bill payment experience and transform it into a rewarding one, giving the customers the financial freedom to do the things that they care about. The idea is to alter the culture of late payments and fees, depleting credit score and the hassle of paying bills. We also believe we have a social responsibility to reduce the credit card debt that has been haunting the US market, by motivating users to pay back early, pay back more and enjoy more rewards,” said Sahil Kumar, CEO, and founder of Fyncr.

With a vision to reform the FinTech space in the country, Fyncr was founded by Sahil Kumar, a seasoned professional with in-depth experience and understanding of the fintech and payments industry. Before Fyncr, Sahil managed projects at Accenture’s largest global consulting arm for the Hi-Tech vertical in Asia, including launching and managing Google Pay in the world’s largest FinTech market. He was responsible for leading teams and building the offering from launch to the #1 payments service.

What sets Fyncr apart as a mobile app is its unique interface that allows customers to track and pay their individual credit card bills periodically from any account. Customers can view, manage, and pay their credit card bills (issued by any bank) from any other or similar bank. For every dollar paid, they accrue an equal number of FYX that can be redeemed across a plethora of brands. Fyncr’s simple and secure design eliminates the need for any additional software or apps to make credit card payments.

Security is key. Fyncr uses multiple layers of security to ensure that customers have a seamless experience without worrying about compromising their sensitive financial data.

  • Fyncr is PCI DSS certified.
  • Fyncr uses bank-grade encryption and works with the world’s most trusted financial. institutions, like Visa, Mastercard, Discover, and AMEX, and financial services companies such as Plaid, Yodlee, and Equifax.
  • Fyncr never stores customers’ bank/credit data, allowing them to communicate directly with banks.

Fyncr App Key Features

  • Autopay – Pay the minimum, custom, or total amount due and plan payments from chosen payment sources
  • One-Stop Shop – Manage multiple credit card bill payments and statement details in one place
  • Rewards called FYX- Secure endless rewards to claim from 500+ brands across electronics, food, restaurants, fashion, beauty, retail, travel, financial, healthcare, services, etc. Registration on Fyncr includes $1000 worth of FYX reward points to help kickstart the users’ experience
  • Alerts – Customers get regular notifications and alerts to pay and know what they save by paying on time

“Our top priority as a fintech company is to ensure the safety of our customers’ data. Fyncr is built from the ground up with customer experience design and security at its very core. We worked with experts every step of the way to make sure every click, tap, or swipe was intuitive and simple. This all-in-one experience is powerful in saving time, money and bringing peace of mind, knowing your credit card bill payments are secure and well-managed,” adds Sahil.

Fyncr’s team of experts – from Accenture, Dell, Publicis, and others – distill decades of tech & fintech wisdom into the company. Fyncr has so far raised $3 million funded by a mixed bag of successful and tech-savvy entrepreneurs, individual investors that represent themselves as angels or own small investment companies.

The US audiences’ belief in Fyncr’s value proposition is justified by the fact that the

Early-stage startup has amassed over 20,000 installs in less than two months.

About Fyncr

Fyncr Inc. was founded in 2020. Through its mobile app, Fyncr is the only platform that allows customers to store, view, and pay all their credit cards from any bank account in one place. It is also the only solution provider that further rewards its users with points for making bill payments, redeemable across any merchant of their choice. For more information, visit:

http://www.fyncr.com

Share article on social media or email:

[ad_2]

U.S. Oral Surgery Management Announces First Partnership in Massachusetts

[ad_1]

Headquartered in Irving, Texas, USOSM has partner practices spanning 19 states.

We’re excited to announce our first partnership in Massachusetts, and we’re honored that it is with Central Mass Oral Surgery, which is well known for its integrity and high quality patient care.

U.S. Oral Surgery Management (USOSM) – a specialty management services company that exclusively serves premier oral and maxillofacial surgeons – is announcing a new partnership with Central Mass Oral Surgery PC, an oral and maxillofacial practice treating patients in Leominster and Gardner, Massachusetts. Headquartered in Irving, Texas, this is USOSM’s first partnership in the state.

“We’re excited to announce our first partnership in Massachusetts, and we’re honored that it is with Central Mass Oral Surgery, which is well known for its integrity and high quality patient care,” said Richard Hall, USOSM president and CEO.

Like all USOSM partner practices, Central Mass Oral Surgery will retain complete clinical autonomy throughout the partnership. Central Mass Oral Surgery has three doctors: Carmine Colarusso, DMD, Shant Baran, DMD, and Mikhail Kobakov, DMD, who are dedicated to providing patients with high-quality, compassionate and comprehensive care. They provide a full scope of oral and maxillofacial services from bone grafting and wisdom teeth removal, to tooth extractions, pre-prosthetic surgery, oral pathology, apicoectomy procedures and more.

“USOSM will focus on what it does best – business – and we’ll focus on what we do best – caring for patients. The business details are important and they need to be taken care of, but we aren’t business experts and it’s not something we’re passionate about. We’re OMS experts and our passion is caring for our patients,” said Dr. Carmine A. Colarusso of Central Mass Oral Surgery.

Headquartered in Irving, Texas, USOSM has partner practices spanning 19 states. They include Texas, Colorado, Georgia, Tennessee, Minnesota, Alabama, Oklahoma, Louisiana, South Carolina, Mississippi, Florida, Indiana, Kentucky, Arizona, California, Oregon, Virginia, Washington and Massachusetts. A shared services organization, USOSM collaborates with premier oral and maxillofacial surgeons to offer a partnership solution for continued and accelerated practice success. USOSM provides operational, marketing and administrative support services, reinvests resources, and applies best practices to improve clinical and financial performance and produce steadier, more profitable growth for all. For more information, visit https://www.usosm.com/.

Share article on social media or email:

[ad_2]

The B100 Method Brings Heart Disease Prevention to the Comfort of Your Home

[ad_1]

www.b100method.com

“Just as DNA genetic testing is synonymous with genealogy, B100 will be synonymous with heart disease prevention,” says Dr. Bereliani. “This is the future of cardiology.”

Launching today in the midst of American Heart Month is the B100 Method, an innovative, groundbreaking tool assisting in the prevention of heart disease. This one-of-a-kind, at-home heart test is driven by sophisticated data, up-to-the-minute science, and is backed by well-known Beverly Hills cardiologist Dr. Arash Bereliani who has more than 20 years of clinical practice insights. Dr. Bereliani describes the B100 home test as easy, painless, and comprehensive. While this test is not designed to replace your cardiologist, B100 will place you at the helm of advocacy for your own heart health from the convenience of your home.

“B100 fills a much-needed market niche as the only home-based solution that directly addresses the heart health epidemic,” remarks Dr. Bereliani, co-founder of the B100 Method. “This home test is designed in a way that can assess your heart disease risk in the next 10-15 years, providing immediate, actionable steps to improve your risk factors.”

According to the CDC, 659,000 people in the United States die from heart disease each year (that’s 1 in every 4 deaths) and one person dies every 36 seconds in the USA from cardiovascular disease. Heart disease remains, by far, the nation’s #1 killer and most costly disease, but it is also preventable. Over the past two years, many have put off seeing doctors and specialists due to the global pandemic. This delay is driving heart disease back to the forefront of our attention as much needed heart health tests are skipped or come too late. What is the preventative solution for heart disease? The B100 Method.

The B100 Method home test is easy with three simple steps from start to finish:

1. Provide Your Information; Including an Online Quiz Assessment, Blood Pressure, Body Measurements, and Nitric Oxide: The quiz takes only 10 minutes to complete, with questions pertaining to your lifestyle and family history that will provide deep insight into your heart health. Body measurements will guide B100 in how your body mass is distributed, while the nitric oxide saliva test will evaluate if levels are within the range for heart healthy conditions. Up to 4 Blood Pressure readings will provide a more detailed picture than a single reading in a Dr’s office can.

2. Collect and Return Your Sample for Professional Lab Work: The blood sample is easy and painless, with no needles required, and uses a patented, FDA-approved blood collection device (not a finger prick!). B100 provides the most advanced cardiac lab panel available, more in depth than those checked by most doctors. Mail the samples back to the lab for processing in the provided prepaid envelope.

3. Receive and Read Your Results: B100 will evaluate the provided information and lab results against its overall database, and use the proprietary B100 algorithm to generate a “LubDub” grade (your heart’s sound), which can range from an A, indicating very low risk for developing heart disease, to a D which tells you that you are at high risk for heart disease and should be under the care of a cardiologist. A cardiologist in your area can be recommended if you don’t already have one.

Along with your LubDub grade, you will also receive comprehensive information from your home test results and suggestions from Dr. Bereliani regarding your next steps to optimize your heart health. The provided recommendations are extremely thorough and will provide a step-by-step analysis of each factor that is a risk for you personally, based on your test results.

The B100 Method is a natural addition to your regular doctor visits that goes beyond the typical testing done at the doctor’s office and more accurately predicts heart disease risk. The B100 Method also offers additional extended testing and home health options, including genetic marker tests and a range of supplements.

“Just as DNA genetic testing is synonymous with genealogy, B100 will be synonymous with heart disease prevention,” says Dr. Bereliani. “This is the future of cardiology.”

You can order the B100 Method Home Test today and the test should arrive directly into your mailbox in less than 7-10 business days.

MORE ABOUT B100:

B100 fills a much-needed market niche as the only home-based solution that directly addresses the crucial heart health epidemic. We are driven by sophisticated data, up-to-the-minute science, and backed by a well-known cardiologist with over 20 years of clinical practice insights. B100 will be the heart health leader of digital healthcare and the only brand consumers should trust with their hearts at home. You can find us on Facebook and Instagram.

Share article on social media or email:



[ad_2]

Press Release News Wire Service